BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in BridgeBio Pharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 201
- +3 vs. Q1 2021
- Shares held
- 142.7M
- +1.60M (+1.1%) vs. Q1 2021
- Total value
- $8.70B
- +$8.58M (+0.1%) vs. Q1 2021
- New holders
- 30
- 81 more added
- Sold out
- 27
- 60 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1.89B | 7.68% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −118,546−100.0% | Sold out |
| Formula Growth Ltd | 0 | $0 | 0.00% | −80,089−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −75,995−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −23,985−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −23,890−100.0% | Sold out |
| Windsor Creek Advisors, LLC | 0 | $0 | 0.00% | −18,400−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −16,081−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,889−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −10,816−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −6,193−100.0% | Sold out |
| US Financial Advisors, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −5,131−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −4,156−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −4,250−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −3,978−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −3,738−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −3,668−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −1,508−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,103−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −284−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |